Sep 22 | Mar 22 | Sep 21 | Mar 21 | Sep 20 | |
---|---|---|---|---|---|
Income Statement | - | ||||
Total Revenue | - | - | - | - | - |
Gross Profit | - | - | - | - | - |
EBIT | - | - | - | - | - |
EBITDA | - | - | - | - | - |
Net Income Common Stockholders | - | - | - | - | - |
Balance Sheet | - | ||||
Cash, Cash Equivalents and Short-Term Investments | £ 8.60M | £ 8.61M | £ 9.91M | £ 12.32M | £ 6.42M |
Total Assets | £ 2.70B | £ 2.67B | £ 2.25B | £ 1.84B | £ 1.63B |
Total Debt | £ 496.33M | £ 438.66M | £ 427.60M | £ 353.37M | £ 313.02M |
Net Debt | £ 487.73M | £ 430.05M | £ 417.69M | £ 341.04M | £ 306.60M |
Total Liabilities | £ 543.73M | £ 486.00M | £ 473.20M | £ 388.40M | £ 351.49M |
Stockholders Equity | £ 2.15B | £ 2.18B | £ 1.78B | £ 1.45B | £ 1.28B |
Cash Flow | - | ||||
Free Cash Flow | - | - | - | - | - |
Operating Cash Flow | - | - | - | - | - |
Investing Cash Flow | - | - | - | - | - |
Financing Cash Flow | - | - | - | - | - |